Stay updated on Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial page.

Latest updates to the Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now displays revision: v3.6.6, replacing the previous revision: v3.6.5. This reflects a minor internal update to the page's versioning information.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 on the page, indicating a content update to the study details. No changes to the study information or functionality are reflected.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision in the page footer now shows v3.6.4, replacing v3.6.3. This reflects a minor maintenance release of the page rather than changes to the study details or outcomes.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision: v3.6.3 now appears on the page, replacing Revision: v3.6.2. This indicates a minor backend update to the page template or content management system.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page revision has been updated from v3.6.0 to v3.6.2, indicating a metadata version change rather than a change to the study details.SummaryDifference0.1%

- Check89 days agoChange DetectedRecruitment status now indicates no participants are being sought, and new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) are added. The Intervention/Treatment heading formatting is standardized and the site revision updated to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial page.